Nikang’s NKT2152 Dosed in First HCC Patient: Phase 1b/2 Trial Begins
NiKang Therapeutics has initiated a global Phase 1b/2 clinical trial evaluating NKT2152, an oral HIF2α inhibitor, in combination with...
Xilio Announces Phase 2 Data for Vilastobart in Metastatic Colorectal Cancer
Xilio Therapeutics announced initial positive Phase 2 data for vilastobart (XTX101), a tumor-activated anti-CTLA-4 antibody, combined with atezolizumab (Tecentriq®)...
ACTG Launches Second HIV Cure Trial in Africa
The AIDS Clinical Trials Group (ACTG) launched the ACACIA study, a Phase 2 trial investigating the use of two...
RS Biotherapeutics Sees Positive Effects of Lead Compound on Human Lung Tissue
RS BioTherapeutics announced positive results from a human lung tissue study of its lead compound, RSBT-001. The study showed...
Nacuity Gets FDA Fast Track for Retinitis Pigmentosa Treatment
Nacuity Pharmaceuticals has received FDA Fast Track designation for NPI-001, an investigational treatment for retinitis pigmentosa (RP). This designation...
Ropidoxuridine Shows Promise in Glioblastoma Trial
Shuttle Pharmaceuticals has reached 25% enrollment in the initial randomized portion of its Phase 2 clinical trial for Ropidoxuridine...
Mainz Biomed starts a next-generation clinical trial for adenoma detection
Mainz Biomed NV launched eAArly DETECT 2, a U.S. feasibility study for its next-generation colorectal cancer (CRC) screening test....
Humacyte Plans IND Filing for Small-Diameter ATEV™ in 2025
Humacyte plans to submit an Investigational New Drug (IND) application to the FDA for its small-diameter (3.5mm) acellular tissue...
AI in Oncology to Hit $11.52B by 2030, with 29.4% CAGR
The global AI in oncology market, valued at US$1.92 billion in 2023, is projected to reach US$11.52 billion by...
Navigating Digital Health and Clinical Trials in Saudi Arabia
In this Q&A, we interview Dr. Tamara Sunbul, a digital health clinical trial leader. Dr. Sunbul discusses the regulatory...